91 Results for "

EphB

" in MedChemExpress (MCE) Product Catalog:
Products (91)

91 Results for "EphB" in MCE Product Catalog:

  • Isoforms Recommended:
9
9 Publications Verification
Cat. No.: HY-13258A
CAS No.: 940310-85-0
Purity:  99.71%
Synonyms: BHG712
Target:  

Ephrin Receptor

Research Areas:  

Cancer

NVP-BHG712 is an oral active EphB4 kinase autophosphorylation inhibitor, with IC50 values of 3.3 nM and 3.0 nM for EphA2 and EphB4, respectively .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-13258
CAS No.: 2245892-85-5
Purity:  99.58%
Target:  

Ephrin Receptor

Research Areas:  

Cancer

NVP-BHG712 isomer, a regioisomer of NVP-BHG712, shows conserved non-bonded binding to EPHA2 and EPHB4 .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-18833
CAS No.: 1135219-23-6
Target:  

Ephrin Receptor

Research Areas:  

Cancer

ALW-II-49-7 is a selective EphB2 kinase inhibitor with an EC50 value of 40 nM in cell .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-107460
CAS No.: 1198408-78-4
Purity:  ≥99.0%
Target:  

Ephrin Receptor

Research Areas:  

Cancer

LDN-211904 oxalate is a potent and reversible EphB3 inhibitor with an IC50 of 79 nM. LDN-211904 oxalate shows good metabolic stability in mouse liver microsomes. LDN-211904 oxalate with Cetuximab (HY-P9905) could be effective in inhibiting STAT3-activated colorectal cancer (CRC) stemness and Cetuximab resistance in CRC .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P75748
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Ephrin type-B receptor 1; ELK; EK6; NET; EphB1; EPHT2; HEK6
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P75236
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: EphB2; Ephrin type-B receptor 2; EK5; DRT; EPHT3; ERK; HEK5; TYRO5
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-16265
CAS No.: 900573-88-8
Research Areas:  

Cancer

JI-101 is an orally active multi-kinase inhibitor. JI-101 inhibits EphB4, VEGFR-2 and PDGFR-β. JI-101 exhibits anticancer activity. JI-101 can be used in research related to ovarian cancer .
loading...
    loading...
Cat. No.: HY-115481
CAS No.: 1980036-18-7
Purity:  99.87%
Target:  

EGFR

Research Areas:  

Others

EphB1-IN-1 (Compound 1) is a potent EphB1 inhibitor with IC50s of 3.0, 15 and 220 nM against EphB1 G703C, EphB1 T697G and EphB1 WT, respectively .
loading...
    loading...
Cat. No.: HY-P5438
Research Areas:  

Others

Srctide is a biological active peptide. (This is a peptide substrate for many protein kinases, such as Blk, BTK, cKit, EPHA1, EPHB2, EPHB3, ERBB4, FAK, Flt3, IGF-1R, ITK, Lck, MET, MUSK, Ret, Src, TIE2, TrkB, VEGF-R1 (Flt-1) and VEGF-R2 (KDR).)
loading...
    loading...
Cat. No.: HY-170517
CAS No.: 3065631-84-4
Target:  

Wee1 Ephrin Receptor

Research Areas:  

Cancer

PKMYT1-IN-8 (Compound 137) is the inhibitor for PKMYT1 with an IC50 of 9 nM. PKMYT1-IN-8 inhibits EPHB3, EPHA1, KIT, EPHB1, EPHA2, EPHA3, and EPHB2with IC50s of 1.79, 3.17, 4.29, 6.32, 6.83, 8.10, and 10.9 μM, respectively. PKMYT1-IN-8 inhibits the proliferation of cancer cell OVCAR3 with GI50 of 2.02 μM .
loading...
    loading...
Cat. No.: HY-136895
CAS No.: 945396-55-4
Purity:  98.44%
Research Areas:  

Cancer

AZ12672857 is an orally active inhibitor of EphB4 (IC50=1.3 nM) and Src kinases. AZ12672857 shows good inhibition of proliferation of c-Src transfected 3T3 cells (IC50=2 nM) as well as autophosphorylation of EphB4 in transfected CHO-K1 cells (IC50=9 nM) .
loading...
    loading...
Cat. No.: HY-P990405

Target:  

Ephrin Receptor

Research Areas:  

Inflammation/Immunology

The Anti-EphB2 Antibody is a CHO expressed human antibody that targets EphB2. The Anti-EphB2 Antibody has a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 150 kDa. The isotype control for the Anti-EphB2 Antibody can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).
loading...
    loading...
Cat. No.: HY-RS04436
Research Areas:  

Others

EPHB4 Human Pre-designed siRNA Set A contains three designed siRNAs for EPHB4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-15268
CAS No.: 1092787-12-6
Research Areas:  

Cancer

PP487 is a selective dual inhibitor of Tyrosine kinase/PI3-K, with IC50 values of 0.017 μM, 0.072 μM, 0.004 μM, 0.01 μM, 0.55 μM, 0.22 μM, and < 0.01 μM against DNA-PK, mTOR, Hck, Src, EGFR, EphB4, and PDGFR, respectively. PP487 can be used in cancer research .
loading...
    loading...
Cat. No.: HY-RS17657
Research Areas:  

Others

Ephb3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ephb3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P990406

Target:  

Inhibitory Antibodies

Research Areas:  

Inflammation/Immunology

The Anti-EphB4 Antibody is a human antibody expressed in CHO that targets EphB4. The predicted molecular weight (MW) of the Anti-EphB4 Antibody is 150 kDa. For the isotype control of Anti-EphB4 Antibody, please refer to Human IgG1 kappa, Isotype Control (HY-P99001).
loading...
    loading...
Cat. No.: HY-157019
CAS No.: 1809170-68-0
Purity:  99.46%
Target:  

Ephrin Receptor

Research Areas:  

Cancer

UniPR1447 is Dual EphA2 and EphB2 antagonist, with an IC50 of 6.6 μM for EphA2−ephrin-A1 binding .
loading...
    loading...
Cat. No.: HY-155684
CAS No.: 3058085-76-7
Research Areas:  

Cancer

SA-PA is an intracellular self-assembled PROTAC based on azide and alkyne. SA-PA is able to selectively degrade VEGFR-2, PDGFR-β and EphB4 proteins in U87 cells. SA-PA can be converted to PROTAC in situ by click reaction with the help of endogenous copper in tumor tissues .
loading...
    loading...
Cat. No.: HY-136358
CAS No.: 1198408-39-7
Target:  

Ephrin Receptor

Research Areas:  

Cancer

LDN-211904 is a potent and reversible EphB3 inhibitor with an IC50 of 79 nM. LDN-211904 shows good metabolic stability in mouse liver microsomes. LDN-211904 with cetuximab could be effective in inhibiting STAT3-activated colorectal cancer (CRC) stemness and Cetuximab (HY-P9905) resistance in CRC .
loading...
    loading...
Cat. No.: HY-N3634
CAS No.: 775351-91-2
Corylifol C is a potent protein kinase inhibitor with IC50 valueS of 8.7, 3.0, 2.1, 6.4, 4.5, 6.2, 2.3, 1.2, 5.1 μg/ml for ARK5, Aurora-A, Aurora-B, AXL, B-RAF-VE, CDK4/CycD1, TIE2, EGF-R, EPHB4, respectively .
loading...
    loading...